Armata Pharmaceuticals Inc (ARMP)
Official siteHEALTHCARE • BIOTECHNOLOGY • AMEX
Market Cap: $111.21M
Last updated: Nov 17, 2026 at 4:16 PM ET
Armata Pharmaceuticals Inc (ARMP) Stock Chart
Armata Pharmaceuticals (ARMP) has a latest price of $2.63 on Nov 17, 2026. Its price fell 64.1% over the past 12 months. The month-end price fell 98.0% over the 10 years through Oct 2026, a compound annual decline of 32.4%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $165.27 in Oct 2016 and its lowest $1.14 in Jun 2023, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart ARMP with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for ARMP.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 48.1%, and over 6 months it fell 68.9%. The month-end price rose 45.8% over the 3 years through Oct 2026, a compound annual rate of 13.4%.
| Period | Change |
|---|---|
| 1 month | -14.3% |
| 3 months | -48.1% |
| 6 months | -68.9% |
| 12 months | -64.1% |
| 12 months, with dividends | -64.1% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +45.8% | +13.4% |
| 5 years | +2.5% | +0.5% |
| 10 years | -98.0% | -32.4% |
Price by Year
Its best calendar year was 2025, when the price rose 239.5%, and its weakest was 2018, when it fell 79.6%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $3.28 | -47.8% |
| 2025 | $6.28 | +239.5% |
| 2024 | $1.85 | -42.9% |
| 2023 | $3.24 | +161.3% |
| 2022 | $1.24 | -77.4% |
| 2021 | $5.48 | +83.6% |
| 2020 | $2.98 | -8.2% |
| 2019 | $3.25 | +12.5% |
| 2018 | $2.89 | -79.6% |
| 2017 | $14.15 | -77.0% |
Trading Range
The price is 28.5% below its 50-day average of $3.68 and 61.5% below its 200-day average of $6.83.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $2.63 | |
| 50-day average | $3.68 | -28.5% |
| 200-day average | $6.83 | -61.5% |
Price Risk
Over 3 years, its largest fall from a peak was 82.2%.
| Measure | Value |
|---|---|
| 1-year beta | 1.03 |
| Largest fall, 1 year | -82.2% |
| Largest fall, 3 years | -82.2% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About ARMP
What is ARMP's 1-year price change?
Armata Pharmaceuticals's price fell 64.1% over the past 12 months. With dividends included, the 12-month total return was -64.1%.
What is ARMP's 5-year price change?
Armata Pharmaceuticals's month-end price rose 2.5% over the 5 years through Oct 2026, a compound annual rate of 0.5%. These figures leave out dividends.
What is ARMP's beta?
Armata Pharmaceuticals's 1-year beta against the S&P 500 is 1.03, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 82.2%.
Is the ARMP chart free?
Yes. Advanced Charting for ARMP is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
ARMP pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors